Table 1 Demographic and clinical characteristics of patients in this study
From: Treatment of coronavirus disease 2019 in Shandong, China: a cost and affordability analysis
Characteristicsa | Patients (n = 70) |
|---|---|
Sex (Male, %) | 45 (64.3) |
Age, years (Median, IQR) | 52 (37–65) |
Residence | |
 Rural | 30 (42.9) |
 Urban | 40 (57.1) |
Pre-existing disease | |
 Any pre-existing disease | 38 (54.3) |
 Cardiovascular disease | 21 (30.0) |
 Endocrine disease | 12 (17.1) |
 Neurological disease | 6 (8.6) |
 Rental disease | 4 (5.7) |
 Respiratory disease | 3 (4.3) |
 Liver disease | 1 (1.4) |
 Malignancy | 1 (1.4) |
Disease Severity | |
 Mild | 55 (78.6) |
 Severe | 4 (5.7) |
 Critically ill | 11 (15.7) |
Drug acquisition | |
 Antivirus | 69 (98.6) |
 Antibiotic | 43 (61.4) |
 Antifungal | 8 (11.4) |
 Immunomodulator | 63 (90.0) |
 Pre-existing diseases | 38 (54.3) |
 Chinese medicine | 70 (100.0) |
Clinical outcomes | |
 Cure | 67 (95.7) |
 Died | 3 (4.3) |
Duration of hospitalization, days (Median, IQR) | 16 (10–23) |